Does magnesium sulphate prevent cerebral palsy in very preterm born infants?

Phase 1

• Conditions: Moderate to severe cerebral palsy; Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]

• Registration Number: EUCTR2011-000735-80-DK
• Lead Sponsor: ene Drasbek Huusom

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-03-21
• Last Update Posted: 8 November 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Female
• Target Recruitment: 560

Inclusion Criteria

Women aged 18 years or older were eligible if they were pregnant with singletons or twins and were expected to give birth within 24 hours at gestational age 24+0 to 31+6 weeks.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 560
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Major fetal anomalies, maternal contraindication to Mgso4, MgSO4 administrated for other reasons (preeclampsia), lack of ability ot read and speak Danish

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified